8th Seattle Patient Conference - Aplastic Anemia

Aplastic anemia - an Osmosis Preview

Webinar: Moderate, Severe, Very Severe Aplastic Anemia 2018

SSBMT Webinar Series on How I Treat Severe Aplastic Anemia Refractory to Immunosuppression - 12 Dec

Impact of Eltrombopag in Refractory Aplastic Anemia

Late-Breaking Abstract: Eltrombopag Improves Response in Severe Aplastic Anemia

The Role of Supportive Care in Severe Aplastic Anemia

Learning About Aplastic Anemia

Highlights from ASH 2016: Aplastic Anemia 2/15/17

RACE: evaluating eltrombopag in severe aplastic anemia

Eltrombopag increases hematologic response in patients with treatment-naïve severe aplastic anemia

Aplastic Anemia and PNH – Update on Diagnosis and Treatment

Exciting new immunosuppressive therapy treatment for aplastic anaemia

Dr. Deol on the FDA Approval of Eltrombopag in Severe Aplastic Anemia

Frontline Shift for Severe Aplastic Anemia After Eltrombopag FDA Approval

Aplastic anemia management: what's new?

Unmet Needs in Severe Aplastic Anemia and Exciting Ongoing Developments

What is “refractory anemia” and “primary anemia”? Are these terms still in use?

What’s New in Aplastic Anemia and PNH? Important Findings from ASH 2018

Webinar: Managing the Dual Diagnosis of Aplastic Anemia and MDS 2018